Walleye Capital
NBP

Walleye Capital’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Walleye Capital’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,000
Closed -$41.6K – 4813
2025
Q3 		$41.6K Buy
+11,000
New +$37.3K ﹤0.01% 4069

Other funds holding NBP

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
ACM
Ariose Capital Management Central, Hong Kong, Hong Kong $234M AUM 640.82% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Walleye Capital's NBP Position: Q4 2025 in Review

Walleye Capital sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q4 2025, closing a stake of 11,000 shares — an estimated $41.6K sold.

Walleye Capital first reported a position in NBP in Q3 2025 and held it in 1 quarter. The position peaked at $41.6K in Q3 2025. 57 funds tracked by Wall St. Rank hold NBP as of Q4 2025.

  • Walleye Capital reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q4 2025 after selling out during the quarter.
  • Walleye Capital sold 11,000 NovaBridge Biosciences American Depositary Shares shares in Q4 2025, an estimated $41.6K.
  • Walleye Capital first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2025 and held it in 1 quarter.
  • Walleye Capital's NovaBridge Biosciences American Depositary Shares position peaked at $41.6K in Q3 2025.
  • 57 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q4 2025.

Based on Walleye Capital's 13F filing for Q4 2025, filed 13 Feb 2026.